Patient Zone - RegMedNet

Regenerative medicine access

Although there aren’t many regenerative medicines or cell therapies that have been approved, there are a number of mechanisms for regenerative medicine access. Most regulatory ...

Finding information, fighting misinformation

Like many emerging fields, the regenerative medicine industry has been surrounded by hype – promotion, whether intentionally or unintentionally, which can exaggerate the benefits ...

Pay-to-participate clinical trials

As more and more regenerative medicines move from development, to clinical trial and finally approval, the number of clinical trials underway has sky-rocketed. According to ...

Patient advocacy

Researchers, developers and manufacturers aren’t the only stakeholders in the regenerative medicine ecosystem. Regenerative medicine patient advocacy has been an important part of ...

Unproven therapies

Although the number of regenerative medicine therapies that have been approved is rapidly increasing, it is still very small in comparison to the number of treatments being advertised ...